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ABSTRACT
While functional roles of several long non-coding
RNAs (lncRNAs) have been determined, the molecu-
lar mechanisms are not well understood. Here, we
report the first experimentally derived secondary
structure of a human lncRNA, the steroid receptor
RNA activator (SRA), 0.87kB in size. The SRA RNA is
a non-coding RNA that coactivates several human
sex hormone receptors and is strongly associated
with breast cancer. Coding isoforms of SRA are also
expressed to produce proteins, making the SRA
gene a unique bifunctional system. Our experimen-
tal findings (SHAPE, in-line, DMS and RNase V1
probing) reveal that this lncRNA has a complex
structural organization, consisting of four domains,
with a variety of secondary structure elements. We
examine the coevolution of the SRA gene at the RNA
structure and protein structure levels using com-
parative sequence analysis across vertebrates.
Rapid evolutionary stabilization of RNA structure,
combined with frame-disrupting mutations in
conserved regions, suggests that evolutionary
pressure preserves the RNA structural core rather
than its translational product. We perform similar
experiments on alternatively spliced SRA isoforms
to assess their structural features.
INTRODUCTION
Completion of the mouse transcriptome project demon-
strated that a large fraction of the mammalian genome
is transcribed into RNA molecules with no potential
for protein coding (1). In light of their poor evolutionary
conservation, these non-coding RNAs (ncRNAs) were ini-
tially thought to have little or no functional capability (2).
However, studies over the past decade have shown that
ncRNAs play critical roles in the cell (3,4). While the func-
tional capabilities of short ncRNAs (e.g. miRNAs and
siRNAs) are well understood, long non-coding RNA
molecules (lncRNAs) represent a largely unexplored area
of the transcriptome. Long ncRNAs often possess
cell-speciﬁc expression proﬁles (5), show intracellular
localization patterns, and are linked to various diseases
including cancer (6). To date, the functional roles of
lncRNA transcripts have been uncovered in signaling
sensors (7), embryonic stem cell differentiation (8), brain
function (5,9), subcellular compartmentalization and
chromatin remodeling (10).
While the functional studies of some lncRNAs have
been performed (11–14), the molecular basis for function
is poorly understood. Two basic mechanistic questions
have yet to be answered: (i) Is the functional performance
dominated by primary sequence or speciﬁc secondary
elements (6)? (ii) Does the RNA exist as an intermixed
RNA–protein complex [e.g. ribosome (15)], or, is the
structure dominated by RNA [e.g. bacterial group II
intron (16)]. Because RNA functional performance is typ-
ically driven by its secondary and tertiary organization,
determining the structural and functional domains of
lncRNAs, as well as sequence speciﬁc requirements, will
lay the foundation for a detailed mechanistic understand-
ing of long non-coding RNAs.
In this study, we report the ﬁrst experimental charac-
terization of the secondary structure of the entire steroid
receptor RNA activator (SRA). This lncRNA is a
coactivator for several nuclear receptors (17) and is
associated with breast cancer (18–21). Among lncRNAs
(200nt–100kb), SRA has the advantage of being short
enough ( 1kb) for mechanistic studies, but long enough
to encapsulate many of the characteristics of long
ncRNAs. While this RNA was originally characterized
to act as a regulatory non-coding RNA (17), subsequently,
coding isoforms of the SRA RNA were found to exist and
code for the SRA protein (SRAP) (22,23).
SRA has been found to participate extensively in
nuclear coactivation for many hormone-related systems,
including the estrogen receptor (17,24–28), androgen
receptor (29), progesterone receptor (17,30), retinoic acid
receptor (31), thyroid hormone receptor (32), dosage sen-
sitive sex reversal protein (DAX1) and steroidogenic
factor-1 protein (SF1) (33), as well as myogenic
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recently shown that SRA together with the dead box
protein p68 mediates insulation function of the CCCTC
-binding factor (CTCF) (36). Coimmunoprecipitation
studies place SRA in multicomponent nuclear receptor
complexes (17,31,37). Direct binding to the SRA has
been observed for the following proteins: pseudo-
uridylases Pus1p and Pus3p (38), RNA helicases p68/p72
(37), nuclear receptor coactivator SRC-1 (17), and nuclear
repressors such as SHARP (26) and SLIRP (28). The
estrogen-signaling pathway is involved in breast tumori-
genesis, as a subset of breast cancer cells express the
estrogen receptor and require estrogen for their growth
and proliferation. Elevated SRA expression proﬁles
have been shown during tumor progression (18–21).
Additionally, the relative ratio of SRA/SRAP expression
differs in breast cancer tumor cells, with higher recovery
rates for patients for whom SRAP is overexpressed (39).
Alterations in SRA expression levels in estrogen-
dependent breast tumorigenesis make this RNA a
promising new tumor-control target (18–21).
A diverse range of coding and non-coding SRA RNA
isoforms is observed in human and mouse organisms. This
expression appears to be tissue-speciﬁc (17,40). The ratio
between coding and non-coding SRA RNA transcripts in
human muscle cells has been shown to be important in
myogenic differentiation (40). To date, up to 20 SRA tran-
scripts have been identiﬁed (40–42). These transcripts pri-
marily differ in (1) their 50- and 30-extensions, (2) point
mutations or (3) possession of either a full intron or
partial portion of the intron. These differences dictate
the coding versus non-coding potential of SRA (23,43).
For example, possession of the 50-extension introduces
initiation codons for protein synthesis, while the intron
insertion causes an amino acid frame-shift or the introduc-
tion of premature stop codons that abort protein synthesis
(43). With the aim of gaining structural insights into
lncRNA function, we performed probing experiments on
three reported RNA transcripts, which constitute major
representatives of the SRA isoform spectrum in humans:
(i) the non-coding isoform (ncSRA), 0.87kb in length,
(ii) the coding isoform (cSRA) with a 50-extension possess-
ing two start codons, both utilized for the synthesis of 224
and 236 amino acid SRAPs, and (iii) a non-coding isoform
of SRA (intSRA) that is an alternatively spliced transcript
possessing a partial intron insertion.
In previous in vivo studies, serial deletions of the SRA
sequence negatively affected the steroid receptor tran-
scriptional activity. In addition, certain fragments of
SRA were shown to lack the functional performance of
the full sequence (30). These results suggested that SRA
functional capabilities are not limited to one particular
substructure, but may require a complex structural organ-
ization of the lncRNA. To assess the secondary structure
of this RNA, we employ several chemical probing tools
along with covariance analysis across multiple species.
These techniques have proven to be indispensable in
building the initial ribosomal RNA secondary structures,
elucidating important structural motifs and secondary
structures in many other RNAs, including introns,
riboswitches and short non-coding RNAs (44–49).
Leontis and coworkers used chemical probing to
validate a variety of designed self-assembled RNA nano-
objects (49). In this work, we utilize the SHAPE method-
ology developed by Weeks and coworkers that has been
recently used to map the secondary structure of the HIV
genome (50). In addition, we support these investigations
with DMS probing, in-line (51) and RNase V1 digestions.
We present the experimentally derived secondary structure
model of the lncRNA, describe its structural architecture
and discuss its evolution.
MATERIALS AND METHODS
RNA synthesis
Double-stranded DNA templates for RNA isoform syn-
thesis were generated using multiple cycles of PCR from
smaller DNA fragments ( ultramers of 150–200nt in size,
IDTDNA). Five to seven DNA pieces, depending on the
desired RNA, were engineered to have overlapping
regions. Two DNA fragments were ﬁrst annealed and
extended by Taq polymerase to generate pre-dsDNA tem-
plates. This was followed by the addition of a third
fragment, accompanied by additional rounds of PCR to
obtain a larger dsDNA template. This stepwise protocol
was continued until all DNA pieces have been utilized.
Additional PCR reactions were performed to (i) amplify
the ﬁnal dsDNA product using reverse and forward
primers and (ii) incorporate the T7 promoter region.
These templates were used in run-off transcription using
a high yield AmpliScribe T7 synthesis kit from Epicentre
Biotechnologies. The RNA products were extracted with
phenol–chlorophorm and further precipitated with the
addition of one volume of 5M ammonium acetate. The
integrity of RNA was checked on agarose and polyacryl-
amide gels.
Chemical probing
Prior to probing, RNA was denatured in water at 94 C for
2min and snap-cooled on ice. Folding was carried out in
1 HMK buffer (50mM HEPES–NaOH pH 8.0, 100mM
KCl, 6mM MgCl2,) for 30min at 37 C. An exception in
the folding protocol was made for in-line probing, which is
described below. In all probing reactions, the ﬁnal concen-
tration of RNA was adjusted to 250nM.
SHAPE. SHAPE probing was performed as recom-
mended by Weeks and coworkers (52) using the
fast-acting 1M7 reagent (53). 1M7 was synthesized from
4-nitroisatoic anhydride using a protocol developed by
Mortimer and Weeks (53). Folded RNA was adjusted
with 1M7 (dissolved in DMSO) to a ﬁnal concentration
of 3mM and incubated at 25 C for 5min. Parallel RNA
samples were treated with the same amount of pure
DMSO to obtain the blank. Modiﬁed RNAs were col-
lected using the standard sodium acetate/ethanol precipi-
tation technique.
DMS. An amount of one-twentieth volume of 10% DMS
in ethanol (or pure ethanol for blank trace) was added
to the folded RNA followed by incubation for 1h on
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volume of stop solution (1M Tris–HCl pH8.0; 1M
B-mercaptoethanol, 1M sodium acetate). To precipitate
the alkylated RNAs, 2.5 volumes of ethanol were added
to the mixture followed by incubation at  80 C and
centrifugation.
In-line. In-line probing reactions were performed as
described previously (51). After the RNA denaturation
step, they were carried out in a 1  in-line probing buffer
(50mM Tris–HCl pH 8.3; 20mM MgCl2, 100mM KCl)
for 46h at 25 C. The products of the in-line cleavage were
precipitated using the sodium acetate/ethanol procedure.
RNase V1. Serial dilutions of RNase V1 (Ambion) were
tested to optimize the conditions of the cleavage. The
optimal cleavage pattern was obtained with the ﬁnal
amount of 0.000125U/ml of RNase V1. The digestion re-
actions were carried out for 20min at 25 C, followed by
the addition of the precipitation/inactivation buffer
(supplied with the enzyme) as outlined in the manufac-
ture’s protocol.
Analysis of chemical probing reactions
Reverse transcription/primer design. The modiﬁcation/
cleavage sites of the RNA were analyzed by primer exten-
sion of ﬂuorophore-labeled primers with the SuperScript
III reverse transcriptase from Invitrogen. DNA primers of
25nt were designed to target the regions of SRA separated
by  150–200nt. Fluorophore-labeling of primers was
achieved using DNA oligos synthesized with an amino
moiety on their 50-end (IDTDNA) and Alexa Fluor 488
amine reactive ester purchased from Invitrogen. The
ﬂuorophore-labeled primers were further puriﬁed on
reverse phase HPLC. Reverse transcription reactions
were performed in the following manner: 6pmol of
RNA (2ml) were mixed with 2pmol of site-speciﬁc
primer (1ml), 1ml of water and 1ml of dNTP mix
(2.5mM). The mixture was heated up for 5min at 65 C
and placed on ice. This was followed by the addition of
2mlo f4   Reverse Transcription buffer and 1mlo f
Superscript III (200U/ml). The 4  Reverse Transcription
buffer was prepared by combining four parts of 5  First
Strand buffer and one part of 0.1M DTT supplied with
the enzyme. The mixture was incubated for 1h at 55 C
followed by additional 15min at 70 C for enzyme inacti-
vation. The mixture was diluted with water to a ﬁnal
volume of 40ml and desalted with micro Bio-Spin
columns ﬁlled with Bio-gel P6 (Bio-Rad Life Science).
One quarter of the mixture (10ml) was dried under the
vacuum and resuspended in 20ml of deionized formamide.
Two dideoxy sequencing reactions were performed in
parallel (A-sequencing and C-sequencing). The reverse
transcription protocol is similar as outlined above except
that the 1ml of water was substituted with 1mlo f1 m M
ddNTP (ddTTP for A-sequencing and ddGTP for
C-sequencing).
Capillary electrophoresis and trace processing. The
products of reverse transcription were resolved by capil-
lary electrophoresis on an ABI PRISM 3100-Avant
genetic analyzer. Prior to loading, the samples were
denatured for 3–4min at 95 C. The sequencing and
probing primer extension reactions were run on either 50
or 80cm capillaries loaded with POP-6 polymer. Traces
were manually aligned and then Gaussian integrated.
Probing reactivity traces were further corrected for expo-
nential decay using the statistical model implemented in
the ShapeFinder software package (54). Reverse transcrip-
tion stops observed in the blank traces were subtracted
from the probing traces. The SHAPE traces were further
normalized by the average reactivities for highly reactive
nucleotides such that the range extends from 0 to 1.5, as
recommended by Vasa and coworkers (54). In-line, DMS
and RNase V1 probing traces were normalized in a similar
fashion.
Comparative sequence analysis (conservation and
covariance analysis)
Multiple sequence alignments of 45 eukaryotic sequences
comprising the full or partial SRA gene were obtained
from the ENCODE project (55). Covariant base pairs
were determined with in-house code that monitors
changes in a given base pair across species, in a manner
similar to Hofacker and coworkers (56). Alignment ﬁgures
were prepared using the Jalview program (57).
RESULTS
Agreement between SHAPE, in-line, DMS and RNase
V1 probing experiments across the entire length of the
lncRNA
The secondary structure of the non-coding SRA transcript
has been assessed by extensive probing investigations
using chemical (SHAPE, in-line and DMS) and enzymatic
probes (RNase V1). These methods utilize different
chemical mechanisms, resulting in either modiﬁcation or
cleavage of RNA molecules depending on their structural
folds. SHAPE, in-line and DMS probe single-stranded
nucleotides, while RNase V1 digests base paired regions.
Probing sites have been analyzed by reverse transcription
using multiple site-speciﬁc primers and capillary
electrophoresis.
The collection of processed data for the entire length of
the lncRNA is summarized in Figure 1. It shows the pro-
cessed reactivities of each nucleotide from SHAPE, in-line,
DMS or RNase V1 probing methods plotted against their
position in the sequence. High-intensity values in SHAPE
(red), in-line (grey) and DMS (brown) plots deﬁne
single-stranded nucleotides of RNA. High-intensity
regions show a high degree of overlap, suggesting that
the results from the three methods are highly consistent
with each other. High-intensity values in RNase V1 (blue)
indicate base-paired nucleotides, which, as expected, are
primarily positioned in the regions showing lower
SHAPE, in-line and DMS reactivities. Enlarged regions
of these plots can be found in Supplementary Figure S1.
Overall, the results from the four methods are consistent
with each other and have been used in aggregate to deter-
mine the structure of the lncRNA.
5036 Nucleic Acids Research, 2012,Vol.40, No. 11Figures 2 and 3 summarize our experimental ﬁndings
and display our experimentally derived secondary struc-
ture, annotated with either SHAPE and in-line reactivities
or DMS and RNase V1 reactivities, respectively. The
lncRNA appears to possess a complex secondary structure
organization consisting of four major domains,
comprising 25 helices in total. To simplify the following
discussion, we also outline the helix nomenclature of the
lncRNA based on several conventions previously applied
to the ribosomal RNA secondary structure. First, the
numbering of the helices was sequential, starting from
the 50-end to the 30-end. Second, helices were differentiated
when they were separated by either (i) a junction, (ii) a
large internal loop (>12nt in total), or (iii) a highly asym-
metric internal loop with zero residues present on one side
and a large number of single-stranded nucleotides (>6nt)
on the other side.
The proposed secondary structure model is consistent
with the probing results: single-stranded regions are
extensively modiﬁed or cleaved by the chemical reagents
targeting single-stranded nucleotides, while base paired
nucleotides are cleaved by RNase V1. A detailed dis-
cussion of the probing data and the resulting secondary
structure is presented below.
Highly mobile and ﬂexible nucleotides of the lncRNA
are mapped by SHAPE and in-line probing
SHAPE probing targets ﬂexible nucleotides of RNA
molecules and does not suffer from solvent accessibility
issues (58). Nucleotides that are extensively acylated at
the 20-OH position by the SHAPE reagent and have a
normalized reactivity >0.5 are considered to be highly
ﬂexible and likely to be single-stranded (Figure 1, red
curve; Supplementary Figure S1, red chart). Nucleotides
that undergo no or relatively little modiﬁcation are
likely to be constrained either by base pairing or
other non-canonical interactions (SHAPE reactivities
<0.5) (59).
Nucleotides, which exhibit high SHAPE reactivities,
are mainly located in the terminal loops, internal
loops and junction regions (outlined in yellow and red
dots—Figure 2). This indicates that these regions are
highly mobile and likely to be single-stranded. Some
examples of such regions include residues belonging to
the terminal loops of H2 and H7, internal loops separating
H11–H12 and H20–H21, and junction regions such as the
multi-way junction connecting helices H8, H9, H10, H15,
H18 and H19. Nucleotides restrained by base pairing
interactions generally show a much lower tendency
toward modiﬁcation (outlined in grey dots or not
outlined). The vast majority of our helices demonstrate
this behavior. There are a few select instances where nu-
cleotides involved in base pairing are also reactive towards
the SHAPE reagent. These tend to be located close to
single-stranded regions or bulges. Speciﬁc examples
occur in H2, H4 and H13. This is also a common obser-
vation from the SHAPE probing of the rRNA, the sec-
ondary structure of which is well known (60). In addition,
minor instances of SHAPE-reactive nucleotides positioned
in the central part of a helix have also been previously
observed in rRNA (60). In certain cases, it appears that
the presence of the GU wobble base pairs might bring
some ﬂexibility to the helical segment. Exceptions to the
above examples are helices H6, H9 and H18, where exces-
sive modiﬁcations have been observed. These local regions
of RNA have the potential to form helices (potential base
pairs are indicated with dashes); however, these same nu-
cleotides can be relatively mobile. For example, H9 can
potentially form a 9-bp stem with three GU pairs and one
GA mismatch. The following helical composition can
explain the relative low stability of such a secondary struc-
ture element. We note that SRA is known to bind multiple
proteins (17,26,28,37,38). Thus, we do not exclude the
involvement of additional stabilizing factors such as
proteins.
To verify the SHAPE probing results, we have also per-
formed in-line probing, developed to study RNA structure
by Breaker and coworkers (51). This method does not
require any speciﬁc chemical reagents. Instead, the tech-
nique utilizes magnesium-catalyzed transesteriﬁcation of
RNA in ﬂexible regions. In general, in-line digestion cor-
responds very closely to the SHAPE results (Figure 1 and
Supplementary Figure S1). For detailed comparison,
Figure 1. Processed probing reactivities versus nucleotide position for entire SRA lncRNA spanning 874nt. Examples of raw traces are shown in
Figures 2–3. Red, plot of SHAPE-probing reactivities for SRA using multiple site-speciﬁc primers; grey, in-line probing reactivities; brown, DMS
reactivities; blue, RNase V1 digestion. SHAPE probing reactivities were normalized by the average reactivities for highly reactive nucleotides. In-line,
DMS and RNase V1 probing reactivities were normalized in a similar fashion. Global cutoff value of 0.5 is drawn for each probing proﬁle.
Nucleic Acids Research, 2012,Vol.40, No. 11 5037Figure 2. Secondary structure of entire SRA lncRNA, based on SHAPE and in-line probing experiments. Both experimental techniques detect
single-stranded regions of RNA. Uncircled nucleotides, normalized SHAPE reactivity<0.3; grey circled nucleotides, 0.3<normalized SHAPE
reactivity<0.5; yellow circled nucleotides, 0.5<normalized SHAPE reactivity<0.7; orange circled nucleotides, normalized SHAPE reactivity>0.7;
purple asterisks, normalized in-line reactivity>0.5; green nucleotides, no probing data. Helices are indicated by H1,...,H25. INSET 1: Raw capillary
electropherograms of RNA region containing helices H12-H13 of domain II. Red, SHAPE reactivity; black, in-line reactivity; green, raw blank trace.
INSET 2: Raw capillary electropherograms of RNA region containing helices H19–H21 of domain III. Red, SHAPE reactivity; black, in-line
reactivity; green, raw blank trace.
5038 Nucleic Acids Research, 2012,Vol.40, No. 11Figure 3. Secondary structure of entire SRA lncRNA, based on DMS and RNase V1 experiments. DMS probing detects single-stranded regions;
RNase V1 digestion detects double stranded helical regions. Uncircled nucleotides, normalized DMS reactivity<0.3; grey circled nucleotides,
0.3<normalized DMS reactivity<0.5; yellow circled nucleotides, 0.5<normalized DMS reactivity<0.7; orange circled nucleotides, normalized
DMS reactivity>0.7; blue arrows, normalized RNase V1 cleavage>0.5; green nucleotides, no probing data. Helices are indicated by
H1,...,H25. INSET 1: Raw capillary electropherograms of RNA region containing helices H12–H13 of domain II. Brown, DMS reactivity;
blue, RNase V1 cleavage; green, raw blank trace. INSET 2: Raw capillary electropherograms of RNA region containing helices H19-H21 of
domain III. Brown, DMS reactivity; blue, RNase V1 cleavage; green, raw blank trace.
Nucleic Acids Research, 2012,Vol.40, No. 11 5039we present an example in inset 2 of Figure 2. This case
shows raw SHAPE and in-line capillary electropherograms
collected for the region of SRA from positions 565–680
(helices H19-H21), where in-line and SHAPE reactivities
are extremely similar in intensities. Examination of
the probing results of the entire transcript shows isolated
instances of signiﬁcantly reduced in-line cleavage in the re-
gions of highly-reactive nucleotides towards the SHAPE
reagent. The following suggests that these residues do not
sample the optimal reaction geometry for transester-
iﬁcation by magnesium ions. An example of this case is
included in inset 1 of Figure 2, which shows SHAPE (red)
and in-line (black) capillary traces for the SRA region
between positions 355–445. In particular, the intensity of
cleavage in the region between positions 370 and 400 is
suppressed signiﬁcantly compared to SHAPE.
RNase V1 maps base paired nucleotides, while DMS
veriﬁes single-stranded nucleotides
To gain more insight into the structural organization of
the lncRNA, we also employ dimethyl sulfate (DMS) and
enzymatic RNase V1 probing on the entire length of the
lncRNA transcript (Figure 1 and Supplementary Figure
S1). DMS targets adenosines and cytosines, which do not
participatein base pairing or other tertiary contacts (61).
RNase V1 generally digests base-paired regions and
stacked single-stranded nucleotides (62–64). While DMS
data helped us to verify the information obtained through
SHAPE experiments, RNase V1 probing contributed to
our understanding of helix formation. In addition, due
to bulkiness of the enzymatic probes, RNase V1 has the
potential to reveal solvent-exposed sites of RNA mol-
ecules. DMS reactivities were analyzed and normalized
in a similar manner as the SHAPE data for easy compari-
son. The DMS probing proﬁle (Figure 3) and the SHAPE
results (Figure 2) clearly demonstrate a strong overlap of
DMS-modiﬁed nucleotides with SHAPE-reactive residues
(see also Supplementary Figure S1). Adenosines and cyto-
sines, which are strongly methylated by DMS (yellow and
red), appear in the majority of single-stranded regions pre-
viously captured by the SHAPE reagent. Detailed
examples of this correspondence can be seen by comparing
raw DMS capillary traces of Figure 3 with SHAPE traces
in Figure 2. However, DMS probing alone was not sufﬁ-
cient to capture all single-stranded elements (e.g. loop
between H19 and H20, and terminal loop of H22).
Nevertheless, more extensive methylation was observed
for the single-stranded regions of H7 and the junction
region connecting helices H18 and H19.
The complete RNase V1 cleavage proﬁle is designated
with blue arrows in Figure 3. Due to the large size of the
enzyme, it is limited to the cleavage of solvent-exposed
sites of RNA molecules (63). For example, the ﬁve base
pair portion of helix H12 was not digested by RNase V1
(see also raw RNase V1 trace in the inset 1 of Figure 3).
Interestingly, the most extensively digested sequences by
RNase V1 belong to helices H2, H3, H7 (near the terminal
loop), H13, H22 and H25. This preference of digestion
sites might indicate that these RNA regions are more
solvent exposed and, therefore, accessible to RNase V1.
Additionally, RNase V1 is known to cleave stacked
single-stranded nucleotides (62). We observe several in-
stances of such action in the internal loop of H14, the
terminal loop of H18 and in the internal loop located
between H20 and H21. The single-stranded nature of
these regions is well supported by SHAPE, in-line and
DMS probing.
LncRNA SRA has a complex structural architecture,
organized into four distinct domains
Based on the experimental data, the derived secondary
structure of the lncRNA appears to be organized in four
major domains. Domain I contains helices H1, H2, H3,
H4, H5, H6 and H7. Domain II contains helices H10,
H11, H12, H13 and H14. Domain III contains H8, H9,
H15, H16, H17, H18, H19, H20 and H21. Domain IV
contains helices H22, H23, H24 and H25 (Figures 2–3).
The overall helical composition of the lncRNA accounts
for 48% of the total number of SRA nucleotides with a
helical density of 1 helix per 34 residues. This RNA is
roughly half the size of the ribosomal subunit (874nt
versus 1542nt) and contains 25 helical segments, 16
terminal loops, 15 internal loops and 5 junction regions.
The current secondary structure of 16S rRNA comprises
45 helices, 31 terminal loops, 26 internal loops and 18
junction regions. Thus, the relative number of secondary
structure elements in SRA is similar to that in 16S rRNA.
The only exception is the relatively low number of
junction regions in SRA. Junctions, however, are the
most difﬁcult RNA structural elements to deﬁne. For
example, only eight junctions of 16S rRNA were initially
determined (44). Interestingly, the majority of purine-rich
sequences are located in the single-stranded regions of
SRA, including junctions, internal loops and certain
terminal loops. This is consistent with the secondary struc-
tures of ribosomal RNAs and riboswitch RNAs, which
both show a similar structural trend of placing purine-rich
stretches of sequence in single-stranded locations. Several
CU and CA non-Watson–Crick pairs are observed in the
lncRNA. This phenomenon is also observed in the human
18S rRNA secondary structure. Finally, we observe an
ACC tri-loop, also found in the human 18S rRNA sec-
ondary structure.
Domains I–III represent the core region of SRA and
are the most conserved across species (Figure 4).
Speciﬁcally, domain I (outlined in yellow) consists of
two independent helices, H1 and H2, followed by a
larger subdomain region with helices H3–H7. Helix H6
contains three CCCC or CCCCC stretches. These
regions exhibit no reactivity towards chemical reagents,
but appear to cause reverse transcriptase pausing at the
nucleotide positions located in between the C-rich regions
(Figures 2 and 3). This could be indicative of a complex
tertiary structure that cannot be easily assessed via
chemical probing. We do not guarantee the accuracy of
the H6 fold.
Domain II (outlined in blue in Figure 4) is deﬁned by a
three-way junction, branching helices H10, H11 and H14.
Subsequently, helix H11 gives rise to the helices H12 and
H13. Domain III (outlined in purple) is the largest
5040 Nucleic Acids Research, 2012,Vol.40, No. 11Figure 4. Conservation diagram of SRA lncRNA across wallaby, opossum, platypus and placental mammals (36 sequences total). Dark grey
nucleotide letters, <90% conserved; bold black nucleotide letters, 90–95% conserved; red nucleotide letters, >95% conserved. Yellow highlighting,
domain I; blue highlighting, domain II; purple/grey highlighting, domain III; green highlighting, domain IV. Dashed boxes, deletions that occurredi n
at least one of 36 vertebrate sequences. If deletions occur in more than one species, then the number of species undergoing deletion at this position is
speciﬁed. Arrows, insertion positions. Number of nucleotides, x, incorporated at insertion site is indicated by ‘xnt’. If insertion occurs in more than
one species, number of species undergoing insertion at this position is speciﬁed. Green ﬁlled boxes, covariant base pairs. Green outlined boxes (not
ﬁlled), base pairs undergoing a change from a Watson–Crick base pair to a GU or UG, which do not have any instances of mismatches across all the
organisms. Pink asterisks, mouse-to-human mutation that stabilizes human RNA helix and is silent with respect to amino acid sequence; brown
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(continued)subdomain of SRA. It is composed of several individual
secondary structure elements including H9, H15, H16,
H17, H18, H19, H20 and H21, which are all locked in a
globular fold by helical stem H8.
Validation of secondary structure by comparing SHAPE
experiments on smaller stretches of RNA sequence to the
full RNA. To validate our structural fold and eliminate
alternatives, we performed SHAPE experiments on
smaller fragments of SRA sequence. If the structural
elements are formed via close-range base pairing in the
context of the entire SRA, we expect them to also base
pair in the context of smaller fragments. We note that the
deletions in RNA sequence may expose secondary
elements that were previously hidden, or affect the ﬂexi-
bility of previously rigid structural elements. These effects
could modify signals introduced by the chemical reagents.
Nevertheless, in order to test our strategy, we randomly
chose two sequences  220nt in size that overlap two
regions of SRA sequence between positions 260–479 and
480–693 (Supplementary Figure S2). The ﬁrst stretch of
RNA (260–479) has signiﬁcant overlap in SHAPE reactiv-
ity with the SHAPE reactivity proﬁle of the full RNA for
positions 360–445. The relative ratio in reactivities
changed slightly; however, the positions of base paired
nucleotides remained the same. The overlap in SHAPE
data suggests that the region occupying positions 360–
445 forms an autonomous secondary structure and com-
prises the well-deﬁned helices H12 and H13 of Domain II.
The second fragment (positions 480–693) allowed us to
resolve the nucleotides from positions 495 to 665. The
SHAPE reactivities of this stretch of RNA are very
similar to the SHAPE reactivities of this sequence in the
context of the entire SRA. Helices H15, H16, H17, H18,
H19, H20 and H21 of domain III, which belong to this
region, do indeed base pair in a close-range and are limited
to this sequence. Therefore, the proposed secondary struc-
ture of entire SRA is in a good agreement with fragment
analysis, which was quite useful in the validation of a
number of our substructures in domains II and III.
Due to high sequence variability, domain IV was not
expected to be highly structured. Surprisingly, this
domain, which undergoes many insertions and deletions
among mammals, is well organized into chain of smaller
helical regions with a slightly lower helical density relative
to the rest of the lncRNA. Because of its low sequence
conservation, we refer to this domain as ‘variable’.
Interestingly, eukaryotic ribosomal RNAs also contain
highly variable regions called expansion segments (65). In
the X-ray structure, these regions are well-deﬁned RNA
helices and participate in the formation of complex
tertiary motifs, necessary for maintaining ribosome
functionality.
Conservation and covariance analysis of SRA secondary
structure
Due to the emergence of both non-coding and coding
RNA transcripts from the SRA gene, we cannot eliminate
the possibility that two evolutionary constraints are placed
on its sequence—ﬁrst to preserve the RNA structure and
second to maintain a protein fold. We note that no anti-
sense RNA has been reported to arise from this gene.
Therefore, conservation was assessed only for the sense
strand. To date, the conservation of the SRA gene has
been examined only in terms of its translational product
across certain vertebrates and species from lower taxa
(42). Our new secondary structure of human SRA allows
us to examine the coevolution of 45 vertebrate SRA se-
quences at the RNA structure and protein structure levels,
which are available through the ENCODE project (55).
We have calculated the conservation values for each nu-
cleotide of the SRA sequence from 36 of these sequences,
ranging from platypus to human. The remaining nine
sequences extracted from chicken, zebraﬁsh and other
phylogenetically distant vertebrates were excluded from
the conservation comparison because they contain only
small portions of the SRA gene (see upper right corner
in Figure 4); however, they were not neglected in further
analysis. Nucleotides with the conservation values >95%
are highlighted in red (Figure 4). Thus, regions abundant
in red are the most conserved regions. These include
helices H1, H2, partial regions of H3, H4 and H5 of
domain I, helices H12 and H13 of domain II and helices
H15, H16, H17 and H18 of domain III. With regard to
RNA structure, we note that terminal loops, bulges and
other looping regions in mammalian SRA are generally
more highly conserved relative to base paired regions.
The most striking feature of the lncRNA secondary
structure is the local region of domain III, occupying pos-
itions 493–586 and comprising a three-way junction
branching helices H15, H16 and H17 (detailed alignment
can be found in Figure 5). This RNA segment could be
important functionally, as 57% of the nucleotides in this
region are 100% conserved across vertebrates, from
platypus to human.
We compared the H15–H17 region with nine sequences
of lower vertebrates, including lizard and several species
of ﬁsh (pufferﬁsh, stickleback, Japanese killiﬁsh and
zebraﬁsh) that were initially excluded from the conserva-
tion calculations (Figure 5B). Interestingly, one of the
lowest organisms in the comparison (zebraﬁsh) still
contains portions of H15. Helices H16 and H17 become
Figure 4. Continued
asterisks, mouse-to-human mutation that is neutral with respect human RNA structure and is silent with respect to amino acid sequence; blue
asterisks, mouse-to-human mutation that destabilizes human RNA helix and is silent with respect to amino acid sequence. Pink diamonds,
mouse-to-human mutation that stabilizes human RNA helix and changes amino acid sequence; brown diamonds, mouse-to-human mutation that
is neutral with respect human RNA structure and changes amino acid sequence; blue diamonds, mouse-to-human mutation that destabilizes human
RNA helix and changes amino acid sequence. Mutations from mouse-to-human tend to stabilize the RNA structure of the lncRNA. Inset:
Phylogenetic tree displays evolution of RNA structural domains across 45 vertebrates possessing the SRA gene. Yellow bars, domain I; cyan
bars, domain II; purple/magenta bars, domain III; green bars, domain IV; ‘===’ and ‘NNN’ denote uncertainty in sequence alignment according
to ENCODE database conventions.
5042 Nucleic Acids Research, 2012,Vol.40, No. 11more stabilized throughout evolution, extending from 3 to
5bp. For comparison, we also show in detail the phylo-
genetic alignment of the region comprising H12 and H13
located in Domain II (Figure 5A). This region is highly
conserved across primates and placental mammals. We
note that Helix H13 is associated with structure-7
(STR-7) of SRA previously proposed by Lanz (30).
There are a number of studies that show the functional
importance of the H13 region, which is directly involved in
protein binding (28). However, H13 is signiﬁcantly less
conserved relative to H15–H18 for a large number of
lower species including chicken, zebra ﬁnch, lizard, frog,
and several species of ﬁsh (pufferﬁsh, stickleback,
Japanese killiﬁsh and zebraﬁsh). Juxtaposition of this
lack of conservation of H13 with the high conservation
of H15–H18 suggests that the H15–H18 region in domain
III may be a very important element of the lncRNA
structure.
The high level of sequence conservation allowed us to
easily determine the positions of covariant base pairs
Figure 5. Sequence alignment for the highly conserved SRA regions. (A) SRA conservation diagram for helices H12 and H13 of domain II
(nucleotide positions 357–440). Left, secondary structure. Annotation is as in Figure 4. Right, sequence alignment across 45 vertebrates. Top line
shows dot-bracket notation of secondary structure. Light blue, complementarity of helix H12; light brown and light green, complementarity of helix
H13. Red, covariant base pairs. (B) Same as (A) for H15–H18 of domain III (nucleotide positions 478–583).
Nucleic Acids Research, 2012,Vol.40, No. 11 5043across 36 organisms. Watson–Crick base pairs, mutated to
other Watson–Crick base pairs, are considered covariant
and are denoted by solid green boxes in Figure 4.
Mutations that interconvert a Watson–Crick base pair
and a GU wobble pair are considered partially covariant
and are denoted by an empty green box in Figure 4.
Helices H2, H3, H4, H6, H7, H8, H9, H12, H13, H14,
H15, H19, H20 and H21 possess at least one covariant
base pair. Covariance analysis was not performed on the
variable domain due to poor sequence alignment in this
region.
Amino acid frame disruptions in the conserved regions
of mammalian SRA suggest the loss of protein-coding
potential for SRAP synthesis
We also examine the impact of nucleotide insertions and
deletions across 36 vertebrates. Insertion sites are denoted
with blue arrows and deletion sites are presented as dashed
boxes in Figure 4. There is a high occurrence of these
events after position 700 in domain IV. Therefore, due
to space limitations, these sites were not outlined in this
ﬁgure.
Insertions and deletions of integral codon length
(i.e. insertions and deletions that are multiples of 3nt)
occur in the regions that show reduced or a complete
lack of sequence conservation between vertebrates.
These insertions and deletions are located primarily in
the single-stranded regions or close to the terminal loops
such as H7 in domain I and H21 in domain III. Insertions
and deletions of integral codon length represent the
majority of all cases and are very common amongst the
various vertebrates.
An interesting feature of the insertion/deletion map
concerns protein coding frame disruption for the SRAP
encoded by the coding isoform of SRA, which is identical
to the non-coding isoform, apart from a short region at
the 50-end. Frame disrupting insertions and deletions are
non-integral codon insertions and deletions (i.e. insertions
and deletions that are not multiples of 3). We observe such
insertions and deletions in well-conserved regions of SRA
such as H10, H12 and H13 of domain II and H15, H16
and H17 of domain III. These insertions and deletions
constitute a small fraction of the total number of the in-
sertion/deletion points and are mainly introduced by three
eukaryotes: pika, microbat and rock hyrax. Interestingly,
these three organisms are not descendants of each other
and belong to different branches of the mammalian phylo-
genetic tree. Thus, it is likely that each of these three
species express only the non-coding form of SRA RNA,
while their ancestors may have expressed both the coding
and non-coding isoforms. The SRA gene of rock hyrax
has a single nucleotide deletion in the H13 of domain II
(also see detailed alignments in Figure 5A). The pika gene
does not have deletions, but has the highest number of
insertions, which primary occur in the helices H12 and
H13. The microbat gene has accumulated a 1-nt insertion
in the junction connecting H10, H11 and H14 of domain
II. This is followed by an additional 1-nt insertion and
1-nt deletion in the junction of H15, H16 and H17 of
domain III (Figure 5B). All three above mentioned
organisms introduce changes that negatively affect trans-
lation, by compromising the amino acid reading frame.
This disruption will have no obvious effect on the RNA
structure. One possible exception may be an insertion in
H13 of pika, where the formation of an alternative 6-bp
stem might be the case. Despite high conservation and
limited number of sequences, the formation of H12 and
H13 is validated by the covariant base pairs outlined in
green in Figure 4. H15 also possesses a covariant base pair
from Myotis lucifugus (Figure 5B). Frame-disruptions in
the conserved regions of the SRA gene suggest that evo-
lutionary pressure in mammals preserves the RNA struc-
tural/functional core rather than its translational product.
The sequence of RNA helix H2 is the most highly
conserved at the protein level and shows a reduced rate
of evolution relative to other regions of the lncRNA
Helix H2 in domain I is highly conserved from the point of
view of RNA and protein structures (Supplementary
Figure S3). Lanz and coworkers show that this RNA
region is important in the coactivation performance of
the lncRNA (30). Site-directed mutagenesis of this RNA
substructure reduced the coactivation performance of this
RNA by 40%. In addition, the formation of well-deﬁned
RNA helical composition is supported by our SHAPE,
in-line, DMS and RNase V1 probing experiments
(Figures 2 and 3). Surprisingly, it was found recently
that the sequence belonging to this helix is the most
conserved at the protein level between human and lower
organisms, including trichoplax. This suggests that the H2
sequence may play an important role in the translated
protein (42). We believe that while this region is function-
ally important at the RNA structure level, it has a signiﬁ-
cantly reduced rate of evolution relative to the remainder
of the lncRNA due to strong constraints imposed by
coding requirements of the SRA gene. This example
provides evidence that different evolutionary rates are
placed on the same sequence. In contrast to H2, the func-
tionally important H13 (STR-7) evolved later and is
absent in lizard, pufferﬁsh and other vertebrates.
Nucleotide mutations from mouse to human produce
more stable RNA helices in human
With the RNA secondary structure of human SRA
(Figure 4) and recent NMR structure of mouse SRA
protein (PDB ID: 2YRU), we can simultaneously assess
the mutational effects of the SRA gene at the RNA struc-
ture and protein structure levels. The solved NMR struc-
ture of mouse SRAP contains amino acids corresponding
to the positions 93–216 (Figure 6). The IUPred package
(66,67) predicts that human SRAP residues 1–90 and
220–236 are highly disordered. We note that while
amino acid positions 13–21 (RGWNDPPQF) of SRAP
are predicted to be disordered, this region corresponds
to the highly structured H2 in Domain I and is highly
conserved at the protein and RNA levels.
Based on the ENCODE SRA multiple sequence align-
ment (55), there are 99 positions in the SRA gene that
have mutated between mouse and human (Figure 4).
A detailed map at the nucleotide level can be also found
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sequence, 48 mutations are silent (asterisks) and do not
change the amino acid (Figure 4). The remaining positions
are missense mutations (diamonds), resulting in the coding
of a different amino acid. We also map the locations
of missense mutations on the NMR structure of mouse
SRAP (Figure 6). In summary, the majority of amino
acid mutations (blue spheres) are positioned in
inter-helical linker regions. In general, these loops lack
secondary structure and generally possess the highest
number of amino acid insertion/deletion sites (68).
However, the possibility of their involvement in active
site formation should not be neglected. We observe only
three amino acid mutants positioned in a helices, which
could alter the helical packing of SRAP: Ile 15, Arg 49 and
Lys 110 (amino acid numbers correspond to protein
databank accession code 2YRU). Cooper and coworkers
have constructed a homology model of human SRAP
based on the NMR structure of mouse SRAP (42),
which adopts a similar ﬁve-helix conformation to that of
mouse. This group has also noticed that mouse SRAP
shares strong structural similarities with yeast splicing
factor prp18, suggesting that SRAP could possess
similar RNA-binding motifs (42).
At the RNA structure level, 58 of 99 mutations have a
stabilizing effect on RNA helix formation. These include
(i) changes from AU base pairs in mouse to GC base pairs
in human, (ii) changes from GU pairs in mouse to GC
base pairs in human, and (iii) changes from non-Watson–
Crick mismatches in mouse to Watson–Crick base pairs in
human. Of the 99 mutations, 32 are neutral and do not
affect the secondary structure fold. These mutations are
positioned in single-stranded regions. We note that it is
possible that these neutral mutations may have positive or
negative effects on tertiary interactions because we do not
know all possible canonical and non-canonical tertiary
interactions involved in the structure. In total, 59% of
all mutations contribute to the stabilization of the
secondary structure, while only 9% have a negative
effect on RNA helix stability. While the mutational
effects at the protein level are not easily assessed, they
appear to be minimal. The mutational contribu-
tions towards stabilization of the RNA structure are
profound.
RMDetect identiﬁes several secondary structure elements
consistent with SHAPE, in-line, DMS and RNase V1
probing
The RMDetect computational tool for structural RNA
module searching was applied to the human ncSRA
isoform alone and to the ENCODE multiple sequence
alignment across 36 organisms (69). In the single
sequence run of RMDetect, the code identiﬁed the
C-loop in H24 of domain IV at positions 769–776 on
the 50-side and 805–813 on the 30-side. Interestingly,
RMDetect also predicts a kink-turn motif in H24 at
779–784 on the 50-side (CUGACC) and 794–802 on the
30-side (GGGAAGAAG). While this differs slightly from
the conﬁguration depicted in Figures 2–4, we emphasize
that this kink-turn predicted by RMDetect is consistent
with all four probing techniques used in this study.
This kink-turn is deﬁned by an AGA bulge and a four
pair stem with AG, GA, GC and GC pairs. When
running RMDetect using the multiple sequence alignment
provided by the ENCODE genome server, RMDetect
identiﬁes a tandem-GA loop at 780–783 on the 50-side
and 795–798 on the 30-side, capped by Watson–Crick
base pairs on each end. We emphasize that domain IV is
highly variable and has poor sequence alignment.
Structural changes in H1 and the H4/H5 junction region
are manifested between coding and non-coding SRA
RNA isoforms
As mentioned previously, a number of SRA transcripts
have been determined to date (40–42). These transcripts
are alternatively spliced variants of the SRA1 gene of
human chromosome 5q31.3 comprising 5 exons and 4
intronic regions. The majority of SRA isoforms are fully
spliced (all four introns are removed), while a few tran-
scripts retain full or partial intron sequences. We decided
to chemically assess the differences between the various
isoforms in order to understand the possible structural
alterations that can be caused by these alternative
splicing events.
We chose three key SRA systems, which represent the
majority of transcripts determined to date in humans: the
original non-coding form, the coding form, and a second,
longer non-coding form (Figure 7). System 1 (Figures 1–4)
is the non-coding form (ncSRA, NCBI ID: AF092038),
which is lacking initiation codons for the translational
machinery and is 222nt shorter than the coding form.
ncSRA is the ﬁrst SRA transcript determined and
proven to act as a non-coding RNA (17). This transcript
possesses an interesting 4-nt mutation relative to the
coding sequence: positions 1–4 of ncSRA have the
sequence CGCU rather than the GAGA sequence
present in the coding form cSRA (Figures 7–8). This nu-
cleotide substitution silences the initiation codon AUG
Figure 6. SRAP protein corresponding to coding isoform of SRA.
NMR structure of mouse SRAP protein (PDB ID: 2YRU) correspond-
ing to positions 271–609 of SRA RNA transcript. Grey rods, a helices
of the protein. Blue spheres, C-a atoms of residues that differ between
mouse and human. Bonds representation is used for mutations from
mouse to human located in a helices. The majority of mutations occur
in linkers connecting helices.
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to UUG. In addition, the substituted nucleotides are able
to participate in the formation of helix H1. System 2 is the
coding isoform of SRA (cSRA, NCBI id: AF293024). In
this isoform, exon 1 is extended by 222nt on the 50-side
relative to the ncSRA isoform. This 50-extension contains
two initiation AUG codons, both utilized in the produc-
tion of 224 and 236 amino acid SRAP proteins (29,70).
System 3 is an alternatively spliced non-coding transcript
of SRA. This isoform (intSRA, NCBI id: DQ286291)
contains a portion of an intron that is normally spliced
out of ncSRA. This intron portion in intSRA exists
between positions 27 and 28 in ncSRA numbering
(Figure 7, upper right). This SRA variant has the same
50-extension as coding isoform (cSRA); however, a
pre-mature stop codon in the intron sequence aborts
translation (43).
We have performed probing experiments (SHAPE and
DMS) on the entire sequences of cSRA and intSRA tran-
scripts and compared them with the ncSRA probing
results. SHAPE and DMS probing traces collected for
the 50-end extension region in the context of the cSRA
and intSRA sequences appear identical (Figure 7 and
Supplementary Figure S5). This suggests that they share
the same structural fold and are not affected by the intron
sequence. The secondary structure of the 50-extended exon
appears to be an autonomous unit of the sequence, con-
sisting of one relatively large domain followed by a smaller
helical segment. Interestingly, one of the AUG initiation
codons is located in the terminal loop of helix CH2.
Possession of the 50-extension did not appear to interfere
with the SRA core sequence: the core sequence remains
almost entirely undisturbed across all non-coding and
coding isoforms. As shown by Hube and coworkers,
cSRA lacks the coactivation performance of ncSRA tran-
script (40). However, when its coding features are dis-
rupted via mutation of the AUG codon, this transcript
has been shown to perform regulatory activities. This cor-
relates well with our observation that the structural fold of
the core sequence across isoforms remains largely un-
changed. The only signiﬁcant changes in SHAPE and
DMS probing occur in the region containing helix H1
and in the junction region connecting H4 and H5,
distant from the intron insertion site and 50-extension.
Raw SHAPE and DMS capillary traces for the H4/H5
junction region are shown in Figure 8D. The changes
are more pronounced in the DMS proﬁle.
In order to fully describe the structural changes,
Figure 8 shows probing annotations for these regions in
the ncSRA, cSRA and intSRA transcripts. Figure 8A
depicts the SHAPE-annotated (left) and DMS-annotated
(right) helix H1 and the H4/H5 junction region for the
ncSRA transcript. Figure 8B presents the probing annota-
tions for the cSRA transcript. Figure 8C shows the
intSRA, which includes a 60nt intron inserted into helix
H1. The ﬁrst four mutated nucleotides of ncSRA, CGCU,
participate in the formation of H1 (Figure 8A). The
coding SRA isoform in Figure 8B lacks these nucleotides.
Figure 7. Alternatively spliced isoforms of SRA. ncSRA, non-coding isoform of SRA; cSRA, coding isoform of SRA; intSRA, isoform of SRA that
contains an intron not present in ncSRA and cSRA. (A) Experimentally determined secondary structure of the region of the coding isoform of SRA
(cSRA) that differs from the non-coding isoform (ncSRA). This region is called the 50-extension. Annotation is same as Figure 2. The cSRA and
intSRA have identical secondary structures in this region. Upper right, schematic of alternatively spliced isoforms of SRA. The ncSRA comprises
fully spliced core of SRA gene (black line). The cSRA possesses an extended exon-1 (blue line) with two initiation codons for SRAP synthesis (green
bars). The intSRA retains a portion of an intron that is spliced out of ncSRA, located between exon-1 and exon-2 of SRA gene (red). (B) Processed
SHAPE and DMS reactivities for cSRA and intSRA 50-end extensions.
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are changed. Likewise, signiﬁcant changes in the DMS
proﬁle of the H4/H5 junction region are also observed
relative to ncSRA (see also raw DMS capillary traces in
Figure 8D). Speciﬁcally, low-reactivity CUC nucleotides
occupying positions 105–107 are almost completely unre-
active, while C99 and A100, located in close proximity, are
highly exposed to DMS methylation. In addition, A96
shows reduced intensity.
In the intSRA (Figure 8C), DMS reactivities of H4/H5
junction region seem to correspond closely to that of
ncSRA. While the H4/H5 junction region appears to be
similar in both ncSRA and intSRA transcripts (non-coding
forms of SRA), this region displays different reactivities
for cSRA (Figure 8D). Since the probing results of the
50-end extensions present in cSRA and intSRA are very
similar, we excluded the possibility that 50-end extension
has any effect on this structural change. As the remainder
Figure 8. Differences in the secondary structures of alternatively spliced SRA RNA isoforms. (A) Secondary structure of non-coding isoform ncSRA
H1 and H4/H5 junction region annotated with SHAPE (left) and DMS (right) reactivities. Annotation is similar to Figures 2–3. Circled green
nucleotides, ﬁrst 4nt (CGCU) differ with respect to the coding isoform (cSRA). The position of the splicing site between exon-1 and exon-2 is
indicated by black arrow. (B) Same as (A), but for coding isoform cSRA. Nucleotides circled in black (GAGA) differ from non-coding isoform
ncSRA. These nucleotides are preceded by an extended region. Additional extension of 222nt is not fully shown due to space limits. Brown arrows
with ‘question marks’ in the DMS-annotated structure (right) show the potential base pair interaction sites between the nucleotides in brown boxes.
(C) Secondary structure model of intron-comprising isoform of SRA (intSRA) H1 and H4/H5 junction region. Structure contains the intron present
in intSRA and displays the changes caused by the intron retention between exon-1 and exon-2. Start and end positions of the intron sequence are
pinpointed by green bars located after position 27 and before 28. Nucleotides of the intronic region are numbered separately (red primed numbers).
Other annotation is as in (A). (D) Raw SHAPE and DMS capillary traces for ncSRA (red), cSRA (blue) and intSRA (black) for the H4/H5 junction
region. Green, blank traces for unmodiﬁed RNA. Nucleotide positions are shown below the traces.
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isoforms, the only possible cause for this structural
change is the region of RNA corresponding to H1.
From the probing results, it is not obvious which nucleo-
tides from H1 of cSRA may interact with the H4/H5
region. This will require future site-directed mutagenesis
studies. However, there are two low-reactive and comple-
mentary sequences in H1 of cSRA that could pair with the
internal loop of H5 (outlined in brown boxes and con-
nected with question mark labeled curves in Figure 8B).
Interestingly, in intSRA, these two sequence sites are
blocked via close-range base pairing with the intron
sequence of intSRA.
Overall, we ﬁnd it intriguing that non-coding isoforms
share a similar fold in the H4/H5 junction region, distinct
from that of the coding transcript. We also note that the
GAGA sequence (positions 1–4 in cSRA, Figure 8B) con-
tributes to the formation of a much stronger Kozak signal
context: GagAUGG, as opposed to GaaAUGa, located
upstream in CH2 of the 50-end extension.
DISCUSSION
Structural architecture plays a key role in understanding
the mechanism of functional RNAs. Before mechanistic
understanding of many functional RNAs (e.g. ribosomal
RNAs, tRNAs, group I and II introns) could be achieved,
extensive secondary structure studies, along with com-
parative sequence analysis, were performed to lay the
foundation for mechanistic studies (44,45,71,72). RNAs
originating from the SRA gene act as regulatory
non-coding RNAs and as coding transcripts, which
produce the protein SRAP. The functions of the SRA
RNA and SRAP often overlap in the estrogen-signaling
pathway (22,73). We used a variety of tools to produce a
secondary structure consistent with SHAPE, in-line,
DMS, RNase V1, and covariance analysis across 36
species. Each probing technique utilizes various mechan-
isms to target nucleotides. We ﬁnd that using the combin-
ation of these tools gives the most comprehensive picture.
DMS probing alone was not sufﬁcient to capture all
single-stranded nucleotides; however, it was indispensable
in the determination of the internal loop of H7 and the
junction region H18/H19, which were not well captured by
SHAPE and in-line probing. The combined assembly of
these complementary data represents convincing experi-
mental evidence supporting the structural organization
depicted in Figure 4.
Previous studies have investigated the functional per-
formance (i.e. coactivation) of SRA and variants of
SRA, including site-directed mutagenesis and deletions
of stretches of sequence. These studies suggested that the
SRA function is not limited to one sub-structure, but
rather requires the full sequence (30). Our new experimen-
tal probing results reveal that the lncRNA is organized
into four domains, with various secondary elements
ranging from small, autonomous helical stems (e.g. H1
and H2 of domain I) to larger structures formed via
long-range base pairing (e.g. H10 of domain II and H19
of domain III). Previous deletion studies showed that
removal of the 30-end (after position 634) results in a
49% decline in the coactivation efﬁciency (30). This is
consistent with our proposed model where such a
deletion would disrupt the formation of three helices
(H19–H21) and the globular fold of domain III (by dis-
rupting H8). Earlier studies also showed that the removal
of the 50-end (positions 1–142) resulted in a 32% decline of
coactivation activity. In our new secondary structure, a
deletion of positions 1–142 leaves domains II–IV intact.
Site-directed mutagenesis of SRA also appears consist-
ent with our secondary structure. Lanz and coworkers
observed no effect on the coactivation performance
when nucleotides G78 and A96 were simultaneously
mutated to C78 and G96. These residues are positioned
in the looping regions of our secondary structure. A
single-point mutation of G123 to A123 also did not
affect the SRA function, consistent with our secondary
fold. Mutations of the UCU622–624 region and C630
resulted in a 40% decline. This data supports our struc-
ture, as these changes result in disruption of H21. We note
that mutants of A246 and G249 result in a 60% reduction
in SRA functional abilities. This could be a result of the
disruption of key tertiary interactions in the junction
region connecting helices H4–H7; however, further
studies are required to test this hypothesis.
The RNA motifs STR-1 (helix H2) and STR-7 (helix
H13), identiﬁed previously by site-directed mutagenesis
(30), are consistent with the proposed secondary structure
model. For example, it has been suggested that STR-1
(H2) forms a stem loop helix interrupted by an A-bulge
and a UC mismatch. Indeed, strong SHAPE and DMS
modiﬁcation sites are observed in the terminal loop
region and in the junction region preceding the helix, sug-
gesting that it is a completely autonomous unit of the
lncRNA. Similarly, STR-7 (H13) has been proposed to
have a stem-loop structure comprising an asymmetric
internal loop. We have probing results consistent with
the overall shape of this RNA motif.
It is sometimes assumed that RNA sequences with poor
conservation lack functional relevance (74), and therefore,
exist as disordered regions with no deﬁned structural
organization. Despite low conservation of domain IV,
this domain is highly structured, containing well-deﬁned
helices and secondary structure motifs. Extensions on the
50-end in the cSRA and intSRA isoforms also exhibit a
well-deﬁned secondary structure.
Additionally, this lncRNA transcript is known to
interact with a variety of proteins, including its own
translation product SRAP, suggesting a possible forma-
tion of a multicomponent RNA–protein complex
(17,26,28,37,40,75). We observe large internal loops pos-
itioned in domain II (between H11 and H12) and domain
III (between H20 and H21), which may become more
structured upon protein binding. This may also be the
case for helices H9 and H18 of domain III. Interestingly,
X-ray crystallography has recently revealed that the ex-
pansion segments speciﬁc for eukaryotic ribosomal
RNAs contain many single-stranded stretches of RNA
that interact with proteins to form highly ordered
non-helical elements (65). For example, expansion
segment ES39L in the large subunit contains three long
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the binding of six ribosomal proteins. This region also
serves to bind the signal recognition particle, which facili-
tates recruitment of the ribosome to the endoplasmic
reticulum.
We employ analysis of conserved regions to address the
following two questions: (i) are these nucleotides primarily
conserved to maintain structure at the RNA level or at the
protein level, or both simultaneously? and (ii) does the
evolutionary pressure apply uniformly across the entire
sequence or should different evolutionary trends be con-
sidered? Comparison across vertebrates shows that the
evolution of the lncRNA structure towards the human
structure occurs in a stepwise manner. For example, the
highly conserved helix H2 of domain I is already present
early in vertebrate evolution, existing in lizard, frog and
several species of ﬁsh (pufferﬁsh, stickleback, Japanese
killiﬁsh and zebraﬁsh). This helix remains largely un-
changed for the rest of vertebrate evolution. H2 is
followed by the appearance of helices H15, H16 and
H17 of domain III in opossum, wallaby and sloth. H12
and H13 of domain II appear later in evolution, present in
armadillo and tenrec. Comparative structural analysis
between mouse and human strongly suggests that a large
number of evolutionary changes occur to stabilize the
RNA structural core, while the mutational effects at
protein level are relatively minimal. Multiple frame-
disrupting insertions and deletions in other mammal se-
quences indicate a signiﬁcant disruption of coding poten-
tial at late times in evolution, compromising many
well-conserved elements at the protein level.
Moreover, it has been previously proposed that alterna-
tive SRA splicing maintains the coding/non-coding tran-
script balance (40,43). The coding/non-coding potential of
SRA transcripts appears to be encoded in its primary
sequence via the presence or absence of initiation codons
or through the introduction of premature stop codons in
the intron. In addition to differences in primary sequence,
we ﬁnd differences in structure between the coding and
non-coding forms in H1 and the H4/H5 junction region.
Several theories on the origins of non-coding RNA
have been discussed previously (76). One of them relies
on the degeneration of the ability to code for protein
(‘pseudogenization’). An example is Xist RNA, a long
non-coding transcript involved in X chromosome inacti-
vation in mammals that originates from the
protein-coding Lnx3 gene (77,78). Interestingly, the Lnx3
gene was still a coding gene in opossum; however, later
vertebrates gave rise to the non-coding Xist RNA, with
the help of frame-shifting mutations in the exon regions
(77). It is not clear whether the transformation of the
protein-coding gene to the non-coding transcript occurs
in a gradual, stepwise mechanism or via a sudden
change. It has been proposed that, at some point in evo-
lution, the non-coding Xist RNA gene might have been
originated gradually, allowing for a period of time where
non-coding and coding isoforms of the gene coexisted
(76). The coding and non-coding isoforms of SRA also
originate from the same gene, suggesting that this gene
system might be a rare and unique capture of this stage
of evolution.
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